{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:25:00Z","timestamp":1790220300116,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Children's Cancer Resaerch Institute"},{"name":"DKMS"},{"name":"Fresenius"},{"name":"Gentium,"},{"DOI":"10.13039\/501100014841","name":"Medac","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014841","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.bbmt.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T11:57:30Z","timestamp":1526299050000},"page":"1848-1855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8406-0793","authenticated-orcid":false,"given":"Jean-Hugues","family":"Dalle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Balduzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Lankester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Yaniv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Wachowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5922-4242","authenticated-orcid":false,"given":"Anna","family":"Pieczonka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bierings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif","family":"Yesilipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Sedla\u00e7ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Ifversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Sufliarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Toporski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Glogova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Poetschger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2018.05.009_bib0010","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","article-title":"Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?","volume":"120","author":"Pui","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0015","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0020","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/S1470-2045(12)70580-6","article-title":"Relapsed childhood acute lymphoblastic leukaemia","volume":"14","author":"Bhojwani","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0025","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/CCO.0000000000000011","article-title":"Management of relapsed acute lymphoblastic leukemia in childhood with conventional and innovative approaches","volume":"25","author":"Locatelli","year":"2013","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.beha.2015.10.002","article-title":"Reasons for optimism in the therapy of acute leukemia","volume":"28","author":"Rowe","year":"2015","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0035","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bjh.12442","article-title":"Predicting relapse risk in childhood acute lymphoblastic leukaemia","volume":"162","author":"Teachey","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/MOH.0b013e328364f573","article-title":"Hematopoietic stem cell transplantation activity in Europe","volume":"20","author":"Gratwohl","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0045","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1200\/JCO.2014.58.9747","article-title":"Stem-cell transplantation in children with acute lymphoblastic leukemia: a prospective international multicenter trial comparing sibling donors with matched unrelated donors\u2014The ALL-SCT-BFM-2003 trial","volume":"33","author":"Peters","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2307\/2530374","article-title":"The analysis of failure times in the presence of competing risks","volume":"34","author":"Prentice","year":"1978","journal-title":"Biometrics"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0055","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Statist"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.seminhematol.2016.07.002","article-title":"Matched unrelated donor transplants\u2014state of the art in the 21st century","volume":"53","author":"Altaf","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0070","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1200\/JCO.2010.30.1325","article-title":"Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005","volume":"28","author":"Arico","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/leu.2009.250","article-title":"Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia","volume":"24","author":"Conter","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bjh.12239","article-title":"Criteria for and outcomes of allogeneic haematopoietic stem cell transplant in children, adolescents and young adults with acute lymphoblastic leukaemia in first complete remission","volume":"161","author":"Hochberg","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcmd.2007.07.004","article-title":"The haploidentical option for high-risk haematological malignancies","volume":"40","author":"Aversa","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0090","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/sj.bmt.1702996","article-title":"Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children","volume":"27","author":"Handgretinger","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0100","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood-2009-03-207001","volume":"115","author":"Klingebiel","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0105","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/leu.2015.243","article-title":"Unrelated cord blood transplantation for childhood acute myelogenous leukemia: the influence of cytogenetic risk group stratification","volume":"30","author":"Michel","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0110","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/pbc.24559","article-title":"Transplant-related mortality following allogeneic hematopoeitic stem cell transplantation for pediatric acute lymphoblastic leukemia: 25-year retrospective review","volume":"60","author":"Mateos","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0115","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/ijc.30249","article-title":"Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia","volume":"139","author":"Mo","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0120","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2016-01-694349","article-title":"Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome","volume":"127","author":"Michel","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.beha.2015.10.008","article-title":"Antibodies: immunoconjugates and autologous cellular therapy in acute lymphoblastic leukemia","volume":"28","author":"Advani","year":"2015","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0130","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1182\/asheducation-2015.1.400","article-title":"The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia","volume":"2015","author":"DeAngelo","year":"2015","journal-title":"Hematol Am Soc Hematol Educ Progr"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ajh.24238","article-title":"CAR T-cells merge into the fast lane of cancer care","volume":"91","author":"Frey","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0140","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.2146\/ajhp150134","article-title":"Blinatumomab: a novel, bispecific, T-cell engaging antibody","volume":"73","author":"May","year":"2016","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.bbmt.2018.05.009_bib0145","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/1078155215618770","article-title":"A review of blinatumomab, a novel immunotherapy","volume":"22","author":"Newman","year":"2016","journal-title":"J Oncol Pharm Pract"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118302611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118302611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:02:31Z","timestamp":1761058951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118302611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1083879118302611"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.05.009","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}